Your browser doesn't support javascript.
loading
RTS,S/AS01E malaria vaccine induces IgA responses against CSP and vaccine-unrelated antigens in African children in the phase 3 trial.
Suau, Roger; Vidal, Marta; Aguilar, Ruth; Ruiz-Olalla, Gemma; Vázquez-Santiago, Miquel; Jairoce, Chenjerai; Nhabomba, Augusto J; Gyan, Ben; Dosoo, David; Asante, Kwaku Poku; Owusu-Agyei, Seth; Campo, Joseph J; Izquierdo, Luis; Cavanagh, David; Coppel, Ross L; Chauhan, Virander; Angov, Evelina; Dutta, Sheetij; Gaur, Deepak; Beeson, James G; Moncunill, Gemma; Dobaño, Carlota.
Afiliação
  • Suau R; ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Rosselló 153 CEK Building, E-08036 Barcelona, Catalonia, Spain. Electronic address: rsuau@igtp.cat.
  • Vidal M; ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Rosselló 153 CEK Building, E-08036 Barcelona, Catalonia, Spain. Electronic address: marta.vidal@isglobal.org.
  • Aguilar R; ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Rosselló 153 CEK Building, E-08036 Barcelona, Catalonia, Spain. Electronic address: ruth.aguilar@isglobal.org.
  • Ruiz-Olalla G; ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Rosselló 153 CEK Building, E-08036 Barcelona, Catalonia, Spain. Electronic address: gemma.ruizolalla@isglobal.org.
  • Vázquez-Santiago M; ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Rosselló 153 CEK Building, E-08036 Barcelona, Catalonia, Spain. Electronic address: miquel.vazquez@isglobal.org.
  • Jairoce C; ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Rosselló 153 CEK Building, E-08036 Barcelona, Catalonia, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Rua 12, Cambeve, Vila de Manhiça, CP 1929 Maputo, Mozambique. Electronic address: chenjerai.jairoce@manhica.net.
  • Nhabomba AJ; Centro de Investigação em Saúde de Manhiça (CISM), Rua 12, Cambeve, Vila de Manhiça, CP 1929 Maputo, Mozambique.
  • Gyan B; Noguchi Memorial Institute for Medical Research, University of Ghana, Ghana. Electronic address: BGyan@noguchi.ug.edu.gh.
  • Dosoo D; Kintampo Health Research Centre, Kintampo, Ghana. Electronic address: david.dosoo@kintampo-hrc.org.
  • Asante KP; Kintampo Health Research Centre, Kintampo, Ghana. Electronic address: kwakupoku.asante@kintampo-hrc.org.
  • Owusu-Agyei S; Kintampo Health Research Centre, Kintampo, Ghana; Disease Control Department. London School of Hygiene and Tropical Medicine, London, UK.
  • Campo JJ; ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Rosselló 153 CEK Building, E-08036 Barcelona, Catalonia, Spain. Electronic address: jcampo@antigendiscovery.com.
  • Izquierdo L; ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Rosselló 153 CEK Building, E-08036 Barcelona, Catalonia, Spain. Electronic address: luis.izquierdo@isglobal.org.
  • Cavanagh D; Institute of Immunology & Infection Research and Centre for Immunity, Infection & Evolution, Ashworth Laboratories, School of Biological Sciences, University of Edinburgh, King's Buildings, Edinburgh, UK. Electronic address: david.cavanagh@ed.ac.uk.
  • Coppel RL; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, Victoria, Australia. Electronic address: Ross.Coppel@monash.edu.
  • Chauhan V; Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Angov E; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA. Electronic address: evelina.angov.civ@mail.mil.
  • Dutta S; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA. Electronic address: sheetij.dutta.civ@mail.mil.
  • Gaur D; Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India; Laboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
  • Beeson JG; Burnet Institute, Melbourne, Victoria, Australia; Central Clinical School, Monash University, Australia; Department of Medicine, University of Melbourne, Australia. Electronic address: beeson@burnet.edu.au.
  • Moncunill G; ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Rosselló 153 CEK Building, E-08036 Barcelona, Catalonia, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Rua 12, Cambeve, Vila de Manhiça, CP 1929 Maputo, Mozambique. Electronic address: gemma.moncunill@isglobal.org.
  • Dobaño C; ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Rosselló 153 CEK Building, E-08036 Barcelona, Catalonia, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Rua 12, Cambeve, Vila de Manhiça, CP 1929 Maputo, Mozambique. Electronic address: carlota.dobano@isglobal.org.
Vaccine ; 39(4): 687-698, 2021 01 22.
Article em En | MEDLINE | ID: mdl-33358704
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas / Malária Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas / Malária Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article País de publicação: Holanda